This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent. Top assignee: Cantero Therapeutics, Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Miguel Xavier Fernandes: Innovator in Glycolate Oxidase Inhibition
Introduction
Miguel Xavier Fernandes is a notable inventor based in San Cristobal de la Laguna, Spain. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that inhibit glycolate oxidase. His work is crucial for addressing medical conditions such as primary hyperoxaluria and kidney stones.
Latest Patents
Fernandes holds a patent for "Triazole glycolate oxidase inhibitors." This invention provides triazole carboxylic acids and related compounds, along with pharmaceutically acceptable salts, which are effective as glycolate oxidase inhibitors. The patent outlines pharmaceutical compositions and methods for treating primary hyperoxaluria, type I (PH), and kidney stones.
Career Highlights
Currently, Miguel Xavier Fernandes is associated with Cantero Therapeutics, Inc., where he continues to advance his research and development efforts. His innovative approach has led to the creation of valuable therapeutic options in the pharmaceutical industry.
Collaborations
Throughout his career, Fernandes has collaborated with esteemed colleagues such as Hans Maag and Robert J Zamboni. These partnerships have enhanced the scope and impact of his research.
Conclusion
Miguel Xavier Fernandes is a prominent figure in the field of pharmaceutical innovation, with a focus on glycolate oxidase inhibitors. His contributions are paving the way for new treatments for serious medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile